| | | | | | | |
 | MODERNA, INC. | -1.26% | 2.61% | -46.39% | -15.12% | 480.43% | 54 855 |
 | LONZA GROUP AG | -0.69% | 0.33% | -28.13% | -3.22% | 71.60% | 40 862 |
| IQVIA HOLDINGS INC. | -0.89% | -2.39% | -26.69% | -10.64% | 52.95% | 39 504 |
| SEAGEN INC. | 6.65% | 9.88% | -6.43% | -2.25% | 119.11% | 24 966 |
| ICON PUBLIC LIMITED COMPANY | -1.77% | -5.93% | -33.07% | -8.18% | 46.98% | 17 153 |
 | CELLTRION, INC. | -2.76% | -12.96% | -28.79% | -46.83% | -21.41% | 15 702 |
| ALNYLAM PHARMACEUTICALS, INC. | -1.02% | -6.14% | -26.18% | -7.88% | 82.13% | 15 279 |
| BIO-TECHNE CORPORATION | -0.94% | -1.38% | -29.58% | -5.95% | 80.78% | 14 449 |
 | PHARMARON BEIJING CO., LTD. | -2.57% | 1.99% | -20.95% | -34.69% | 220.34% | 12 633 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | -1.36% | -2.54% | -38.27% | -27.92% | 75.97% | 11 980 |
| HANGZHOU TIGERMED CONSULTING CO., LTD | -2.92% | 6.87% | -32.85% | -45.11% | 82.65% | 10 833 |
| QIAGEN N.V. | -0.35% | 0.76% | -17.29% | -1.56% | 22.59% | 10 492 |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | 0.02% | 56.23% | 2.34% | 100.70% | 121.12% | 10 017 |
| UNITED THERAPEUTICS CORPORATION | 1.80% | -0.35% | -13.58% | -5.82% | 110.67% | 8 310 |
| SYNEOS HEALTH, INC. | 0.10% | -4.99% | -31.65% | -17.82% | 65.44% | 7 192 |
| | | | | | | |
| | Moyenne | -0.53% | 2.80% | -25.17% | -8.82% | 107.42% | |
| | Moyenne pondérée par Capi. | -0.47% | 1.67% | -28.32% | -10.08% | 151.81% | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Italiano
Nederlands (Nederland)
Nederlands (België)
bourse
Rapport
